The gut microbiota and its role in the development of cardiovascular disease
Expert Review of Cardiovascular Therapy,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 12
Published: Feb. 7, 2025
The
pathophysiology
of
cardiovascular
diseases
encompasses
a
complex
interplay
genetic
and
environmental
risk
factors.
Even
if
traditional
factors
are
treated
to
target,
there
remains
residual
risk.
This
manuscript
reviews
the
potential
role
gut
microbiota
in
development
disease,
as
target.
A
systematic
search
was
conducted
until
30
October
2024
on
PubMed
(MEDLINE),
using
MeSH
terms
[Gut
microbiota]
+
[Dysbiosis]
[Cardiovascular]
[TMAO]
[bile
acids]
[short-chain
fatty
acids].
term
dysbiosis
implies
changes
equilibrium,
with
modifications
composition
functionality
series
additional
factors:
reduced
diversity
uniformity
microorganisms;
short-chain
acid-producing
bacteria;
increased
permeability;
release
metabolites,
such
trimethylamine
N-oxide,
betaine,
phenylalanine,
tryptophan-kynurenine,
phenylacetylglutamine,
lipopolysaccharides;
secondary
bile
acid
excretion,
leading
inflammation,
oxidative
stress,
endothelial
dysfunction
facilitating
onset
pathological
conditions,
including
obesity,
hypertension,
diabetes,
atherosclerosis,
heart
failure.
Attempts
restore
balance
through
different
interventions,
mainly
diet,
have
been
shown
positively
affect
individual
components
metabolites
reduce
disease.
In
addition,
probiotics
prebiotics
potentially
useful.
Fecal
transplantation
is
promising
therapy.
Language: Английский
The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus
Naunyn-Schmiedeberg s Archives of Pharmacology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 11, 2024
Language: Английский
Role of Trimethylamine N-Oxide in Heart Failure
Lele Jing,
No information about this author
Honghong Zhang,
No information about this author
Qiannan Xiang
No information about this author
et al.
Reviews in Cardiovascular Medicine,
Journal Year:
2024,
Volume and Issue:
25(7)
Published: July 2, 2024
Heart
failure
(HF)
is
a
clinical
syndrome
characterizing
by
typical
physical
signs
and
symptomatology
resulting
from
reduced
cardiac
output
and/or
intracardiac
pressure
at
rest
or
under
stress
due
to
structural
functional
abnormalities
of
the
heart.
HF
often
final
stage
all
cardiovascular
diseases
significant
risk
factor
for
sudden
arrest,
death,
liver
kidney
failure.
Current
pharmacological
treatments
can
only
slow
progression
recurrence
HF.
With
advancing
research
into
gut
microbiome
its
metabolites,
one
such
trimethylamine
N-oxide
(TMAO)—has
been
implicated
in
advancement
correlated
with
poor
prognosis
patients
However,
precise
role
TMAO
has
not
yet
clarified.
This
review
highlights
concludes
available
evidence
potential
mechanisms
associated
HF,
hope
contributing
new
insights
diagnosis
prevention
Language: Английский
Early oral anti-inflammatory diet in patients with mild acute pancreatitis:study protocol for a randomized controlled trial (Preprint)
Published: Jan. 8, 2025
BACKGROUND
Early
oral
feeding
in
patients
with
mild
acute
pancreatitis
can
facilitate
early
recovery
and
offer
economic
benefits
such
as
reduced
average
length
of
hospital
stay
hospitalization
costs.
However,
there
is
a
paucity
research
on
nutritional
support
protocols
for
pancreatitis.
Anti-inflammatory
diets
have
been
shown
to
decrease
inflammatory
levels
modulate
intestinal
microbiota,
which
may
confer
advantages
OBJECTIVE
This
study
aims
explore
the
safety
effectiveness
introduction
an
anti-inflammatory
diet
METHODS
single-center
randomized
controlled
trial
where
experimental
group
undergoes
intervention,
while
control
receives
conventional
management.
The
primary
outcome
measures
include
biomarkers
(C-reactive
protein,interleukin-6,
interleukin-10,
tumor
necrosis
factor-α,
nutrition-related
indicators
(BMI,
body
composition,
albumin,
prealbumin),
gut
microbiota.
Secondary
RESULTS
enrollment
participants
commenced
December
2024,
anticipated
completion
date
July
2025.
A
comprehensive
final
analysis
outcomes
planned
October
2025,
following
collection
rigorous
evaluation
all
relevant
data.
CONCLUSIONS
positive
findings
this
novel
clinical
practice
guidelines
CLINICALTRIAL
Chinese
Clinical
Trial
Registry.gov
ChiCTR2400094056;https://www.chictr.org.cn/index.html
Language: Английский
The causal dance: trimethylamine N-oxide, obesity, and acute pancreatitis in pathophysiological harmony
Jie Liu,
No information about this author
P. Ge,
No information about this author
Yalan Luo
No information about this author
et al.
Human Cell,
Journal Year:
2025,
Volume and Issue:
38(3)
Published: March 26, 2025
Language: Английский
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Vicky Yao,
No information about this author
Nairui Fan,
No information about this author
Shuxia Ma
No information about this author
et al.
MedComm,
Journal Year:
2025,
Volume and Issue:
6(5)
Published: April 18, 2025
ABSTRACT
Dysbiosis
refers
to
the
disruption
of
gut
microbiota
balance
and
is
pathological
basis
various
diseases.
The
main
pathogenic
mechanisms
include
impaired
intestinal
mucosal
barrier
function,
inflammation
activation,
immune
dysregulation,
metabolic
abnormalities.
These
involve
dysfunctions
in
gut–brain
axis,
gut–liver
others
cause
broader
effects.
Although
association
between
diseases
caused
by
dysbiosis
has
been
extensively
studied,
many
questions
remain
regarding
specific
treatment
strategies.
This
review
begins
examining
causes
summarizes
potential
representative
imbalance.
It
integrates
clinical
evidence
explore
preventive
therapeutic
strategies
targeting
emphasizing
importance
understanding
dysbiosis.
Finally,
we
summarized
development
artificial
intelligence
(AI)
research
suggested
that
it
will
play
a
critical
role
future
studies
on
combining
multiomics
technologies
AI
further
uncover
complex
drive
personalized
Language: Английский
Inflammation and nutritional status in relation to mortality risk from cardio-cerebrovascular events: evidence from NHANES
Chengzhi Hou,
No information about this author
Xuanchun Huang,
No information about this author
Jie Wang
No information about this author
et al.
Frontiers in Nutrition,
Journal Year:
2024,
Volume and Issue:
11
Published: Dec. 12, 2024
Objective
Inflammation
and
nutritional
status
are
closely
associated
with
the
mortality
risk
of
survivors
cardio-cerebrovascular
events.
This
study
aims
to
evaluate
relationship
between
inflammation
indices
among,
identifying
most
predictive
indices.
Methods
included
cohort
data
major
adverse
cardiovascular
cerebrovascular
events
(MACCE)
from
National
Health
Nutrition
Examination
Survey
(NHANES)
in
1999–2010.
MACCE
is
defined
as
a
composite
myocardial
infarction,
heart
failure
stroke,
at
least
one
three
occurs.
The
main
outcomes
were
all-cause
mortality.
Kaplan–Meier
analysis
receiver
operating
characteristic
curves
used
compare
correlation
seven
inflammatory
(such
Advanced
Lung
Cancer
Index,
ALI)
among
survivors.
A
multivariable-adjusted
Cox
regression
restricted
cubic
splines
identified
index,
optimal
number
nodes
determined
by
Akaike
information
criterion.
Subgroup
sensitivity
analyses
conducted
assess
model
stability.
Results
total
2,045
included.
higher
levels
ALI
serum
albumin
significantly
lower
risks
these
individuals.
Increases
C-reactive
protein
Lymphocyte
Ratio,
Neutrophil
Serum
Albumin
Neutrophil-to-Lymphocyte
Systemic
Immune-Inflammation
Index
(SII),
similarly
correlated
risk.
outperformed
other
indices,
displaying
distinct
L-shaped
nonlinear
both
survivors,
an
inflection
point
90
indicating
lowest
To
left
this
inflection,
each
unit
increase
was
1.3%
decrease
patients.
right,
might
0.2%,
although
change
not
statistically
significant.
showed
that
association
remained
stable
survivor
populations.
Conclusion
Routine
dynamic
monitoring
helpful
for
clinicians
Anti-inflammatory
therapies
appropriate
support
crucial
reducing
Language: Английский